Dendritic cells and interferon-mediated autoimmunity

Biochimie. 2007 Jun-Jul;89(6-7):856-71. doi: 10.1016/j.biochi.2007.04.013. Epub 2007 May 5.

Abstract

Dendritic cells (DCs) are central cells of the immune responses. They can be considered as the most influential antigen-presenting cells in the body because of their unique role in initiating immunity against most types of antigens. Recent studies have clearly established that the state of maturation of DC can be crucial for the ability of these antigen-presenting cells to inhibit or induce T-cell-mediated autoimmune diseases. Type I interferon has been shown to be produced at very high amounts by a specific type of DC (pDC). In recent years, the study of multiple autoimmune diseases has pointed to a central role for type I interferon (IFN-I) in disease pathogenesis, in particular through the IFN-molecular signature deciphered in some of these diseases. One hypothesis would be that IFN directly affects multiple actors of the immune reaction such as T cells and B cells and that it can induce the unabated activation of peripheral dendritic cells. On the other hand, type II IFN has been considered as pathogenic in multiple autoimmune diseases leading to the paradigm of TH-1 type autoimmune diseases. The discovery of the TH-17 type of cells and the protective role IFN-gamma can exert on particular phases of these diseases urge one to re-evaluate this assumption.

Publication types

  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / metabolism
  • Autoimmune Diseases / metabolism
  • Autoimmunity*
  • Dendritic Cells / cytology*
  • Diabetes Mellitus, Type 1 / metabolism
  • Disease Models, Animal
  • Humans
  • Inflammation
  • Interferon-gamma / metabolism
  • Interferons / metabolism*
  • Lupus Erythematosus, Systemic / metabolism
  • Models, Biological
  • Multiple Sclerosis / metabolism
  • Receptors, Interferon / metabolism

Substances

  • Receptors, Interferon
  • Interferon-gamma
  • Interferons